论文部分内容阅读
目的:为提高政府对制药企业研发资助效果、增加企业内部研发投入和提高创新绩效提供参考。方法:在假设的基础上,构建政府研发资助、内部研发投入与创新绩效关系的理论模型,采用回归分析和中介效应分析方法,以江苏省的制药企业为研究对象进行实证研究。结果与结论:所设计的量表具有良好的信度和效度,经实证检验后得到最终的模型,结合各相关系数结果表明除假设3外其余各项假设均可获得验证。其中,政府研发资助对制药企业内部研发投入和创新绩效均存在促进效应,内部研发投入在政府研发资助与创新绩效之间起到完全中介作用,即政府研发资助对创新绩效有间接的促进作用,其影响系数为0.405。建议政府应适当增加对制药企业的研发资助,充分发挥财政资金的引导作用;制药企业则需重视内部研发投入,建立其在创新体系中的主体地位等。
OBJECTIVE: To provide reference for government to enhance the effect of R & D subsidy for pharmaceutical enterprises, increase internal R & D investment and improve innovation performance. Methods: On the basis of assumptions, a theoretical model of the relationship between government R & D funding, internal R & D investment and innovation performance was constructed. Empirical analysis was made on the pharmaceutical enterprises in Jiangsu Province using regression analysis and mediation effect analysis. RESULTS AND CONCLUSION: The designed scale has good reliability and validity. After the empirical test, the final model is obtained. The results of the correlation coefficients show that all the assumptions except the third hypothesis can be validated. Among them, government R & D funding has a positive effect on the internal R & D investment and innovation performance of pharmaceutical companies. Internal R & D investment plays a complete intermediary role between government R & D funding and innovation performance, that is, government R & D funding plays an indirect role in promoting innovation performance. The impact coefficient is 0.405. It is suggested that the government should increase R & D funding for pharmaceutical companies appropriately and give full play to the guiding role of financial funds. Pharmaceutical companies should pay attention to internal R & D investment and establish their dominant position in the innovation system.